Consortium Receives $900K Grant from NIH to Develop Nanomedicine Research Ethics
OCTOBER 12, 2009—The National Human Genome Research Institute at the National Institutes of Health (NIH) has awarded the University of Minnesota's Consortium on Law and Values in Health, Environment & the Life Sciences a grant of $914,044 as part of the American Recovery and Reinvestment Act (ARRA) for the two-year project, "Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight."
This project will produce the first systematic and comprehensive recommendations on how to protect human participants in research on nanodiagnostics and nanotherapeutics, including drugs, devices, and gene therapy using nano-vectors. Professor Susan M. Wolf, J.D., is the Principal Investigator. Co-investigators are Professors Jeffrey McCullough, M.D.; Ralph Hall, J.D.; and Jeffrey Kahn, Ph.D., MPH. The project working group includes top scholars from across the nation.
This is the second NIH-funded grant awarded to the Consortium in the last two weeks. The Consortium also received a grant of $911,559 for the two-year project, "Managing Incidental Findings and Research Results in Genomic Biobanks and Archives."
For more information on the Consortium's research and Professor Wolf, visit www.lifesci.consortium.umn.edu.